Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.

doi:10.1080/19336918.2023.2258539

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.

Cell adhesion & migration - 1 Dec 2023

Panneerselvam Sugan, Wilson Cornelia, Kumar Prem, Abirami Dinu, Pamarthi Jayakrishna, Reddy Mettu Srinivas, Varghese Joy

Abstract excerpt

Hepatocellular carcinoma (HCC) is the seventh most highly prevalent malignant tumor globally and the second most common cause of mortality. HCC develops with complex pathways that occur through multistage biological processes. Non-alcoholic fatty liver disease, metabolic-associated fatty liver disease, alcoholic liver disease, autoimmune hepatitis, hepatitis B, and hepatitis C are the causative etiologies of HCC....

Topics

Humans
Carcinoma, Hepatocellular
Liver Neoplasms
Molecular Targeted Therapy
Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 37726886
DOI: 10.1080/19336918.2023.2258539
PMCID: PMC10512929

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics